While hormone-secreting pancreatic islet cells (e.g., ? cells and cells) have been identified to play key roles in glucose homeostasis, our understanding of the processes important to normal pancreatic organogenesis and leading to altered metabolic states such as type 2 diabetes (T2D) is still limited. The low availability of human islets and the lack of experimental methods to comprehensively analyze islet cells and their tissue environments restrict our ability to map cell signaling pathways and metabolism. Despite substantial progress towards treatments and cures, much remains unknown about the specific signaling and damage pathways that contribute to -cell dysfunction. A more fundamental understanding of islet development and diabetes pathophysiology is required to help direct diagnoses, prognoses, treatments, and therapies and likely begins at the molecular level. In this way, novel biochemical understandings can be translated to insights on pancreatic development and disease progression, ultimately leading to the identification of new potential biomarkers and therapeutic targets. The proposed discovery-based research herein will provide molecular-level insight on pancreatic islet architecture, function, and development by combining a form of new molecular imaging technology, matrix-assisted laser desorption/ionization imaging mass spectrometry (MALDI IMS), with existing validated approaches. This technology is well suited to measuring the complex array of molecular information (e.g., lipids and proteins) present in cellular tissue and provides for an untargeted measurement method, which is ideal for the discovery of new molecules important to pancreatic function.
We aim to utilize such in situ tissue-based IMS techniques to develop much more complete molecular maps for the different pancreatic endocrine cell types, allowing us to gain insight as to the cell signaling pathways involved in pancreatic development and disease progression. These IMS techniques will be used to specifically define the lipid and protein molecular signatures of normal mouse islets and correlate these maps to functional changes observed in the presence of obesity and insulin resistance. This will allow us to establish those lipid and protein signaling molecules crucial to lipotoxicity and islet dysfunction in the well-studied ob/ob mouse model. Finally, these IMS approaches will be expanded to perform a longitudinal study identifying differences in protein and lipid profiles of human pancreatic islet cells throughout organogenetic development from the juvenile to the adult stages, and determining how these biochemical changes relate to morphological and architectural changes in the tissue. The molecular profiles produced by these interdisciplinary studies will provide insights on the cell signaling mechanisms important in pancreatic maturation and disease progression and will aid in the design of novel therapies and strategies to sustain islet mass and function.

Public Health Relevance

Diabetic and prediabetic diseases affect an estimated 97.8 million people in the United States, causing serious health complications including heart disease and stroke, high blood pressure, blindness, kidney disease, neuropathy, and amputation which all contribute to hundreds of thousands of deaths annually and resulted in over $245 billion in medical costs and reduced productivity in 2012 alone. Hormone-secreting pancreatic islet cells (e.g., ? cells and cells) play key roles in glucose homeostasis and derangement of these cells leads to altered metabolic states such as type 1 or type 2 diabetes. However, despite the well-known fact that islet cells are vital to proper organ function, surprisingly little is known about human islet architecture and mechanistic functionality, especially as it relates to pancreatic development and to much better studied mouse models.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32DK105841-01
Application #
8908974
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Castle, Arthur
Project Start
2015-07-22
Project End
2016-07-21
Budget Start
2015-07-22
Budget End
2016-07-21
Support Year
1
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Biochemistry
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37240
Prentice, Boone M; Caprioli, Richard M; Vuiblet, Vincent (2017) Label-free molecular imaging of the kidney. Kidney Int 92:580-598
Zubair, Faizan; Prentice, Boone M; Norris, Jeremy L et al. (2016) Standard Reticle Slide To Objectively Evaluate Spatial Resolution and Instrument Performance in Imaging Mass Spectrometry. Anal Chem 88:7302-11
Prentice, Boone M; Chumbley, Chad W; Hachey, Brian C et al. (2016) Multiple Time-of-Flight/Time-of-Flight Events in a Single Laser Shot for Improved Matrix-Assisted Laser Desorption/Ionization Tandem Mass Spectrometry Quantification. Anal Chem 88:9780-9788
Prentice, Boone M; Caprioli, Richard M (2016) The Need for Speed in Matrix-Assisted Laser Desorption/Ionization Imaging Mass Spectrometry. Postdoc J 4:3-13